Ichiro Umemura

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 9 (Patent Applications = 1)

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 106(Granted Patents)

Location History:

Ibaraki, JP (2006 - 2013)
Tsukuba, JP (2007 - 2013)

Company Filing History:

1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2013

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8440682 - 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors (2013-05-14),

2. 8431589 - 2,4-diaminopyrimidine derivatives (2013-04-30),

3. 8420641 - Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives (2013-04-16),

4. 8410275 - Bicyclic derivatives as CETP inhibitors (2013-04-02),

5. 8263590 - Pyrimidine derivatives (2012-09-11),

6. 8232403 - Bicyclic derivatives as CETP inhibitors (2012-07-31),

7. 8193349 - 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors (2012-06-05),

8. 7964592 - 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders (2011-06-21),

9. 7943627 - 2,4-diaminopyrimidine derivatives (2011-05-17),

10. 7893074 - 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders (2011-02-22),

11. 7659293 - α-Amino-N-hydroxy-acetamide derivatives (2010-02-09),

12. 7291634 - α-amino-N-hydroxy-acetamide derivatives (2007-11-06),

13. 7112611 - 1g(α)-amino-N-hydroxy-acetamide derivatives (2006-09-26),

Title: Ichiro Umemura: Innovator in Pharmaceutical Chemistry

Introduction

Ichiro Umemura is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 13 patents to his name, Umemura's work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest innovations, Umemura has developed 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors. This invention provides a compound of formula (I), wherein the variants R1, R2, R3, R4, R5, R6, R7 are defined, and the compound serves as an inhibitor of CETP. This advancement can be employed for the treatment of disorders mediated by CETP or responsive to its inhibition. Additionally, he has worked on 2,4-diaminopyrimidine derivatives, which are useful in disorders where ZAP-70 and/or Syk inhibition plays a role, particularly those caused by malfunctions in signal cascades connected with FAK.

Career Highlights

Throughout his career, Umemura has collaborated with notable companies such as Novartis AG and Irm LLC. His work in these organizations has allowed him to further his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Umemura has worked alongside talented colleagues, including Naoko Matsuura and Osamu Ohmori. Their collaborative efforts have enhanced the research environment and fostered innovation in their respective fields.

Conclusion

Ichiro Umemura's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.